GS
70
-2
SO
48
-29
DUK
55
3
ADSK
56
-2
MLM
61
-5
STX
73
-5
AMG
71
-3
TSCO
51
-17
DRI
61
5
A
40
-3
GRMN
37
-8
UAL
72
-13
ADBE
56
4
EIX
56
2
EQIX
59
6
AMT
30
-6
TROW
56
-11
AIZ
76
13
DAL
70
-2
NEE
50
-4
GS
70
-2
SO
48
-29
DUK
55
3
ADSK
56
-2
MLM
61
-5
STX
73
-5
AMG
71
-3
TSCO
51
-17
DRI
61
5
A
40
-3
GRMN
37
-8
UAL
72
-13
ADBE
56
4
EIX
56
2
EQIX
59
6
AMT
30
-6
TROW
56
-11
AIZ
76
13
DAL
70
-2
NEE
50
-4
Financhill
Back

Experian Plc Vs. MiNK Therapeutics, Inc. Industry Stock Comparison

Sell
38

EXPGF
Experian Plc

Last Price:
$45.61
Seasonality Move:
4.4%
Sell
32

INKT
MiNK Therapeutics, Inc.

Last Price:
$11.51
Seasonality Move:
-18.07%
Sell
38
Experian Plc (EXPGF) is a Sell

Is Experian Plc a Buy, Sell or Hold?

  • The current Experian Plc [EXPGF] share price is $45.61. The Score for EXPGF is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • EXPGF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
MiNK Therapeutics, Inc. (INKT) is a Sell

Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?

  • The current MiNK Therapeutics, Inc. [INKT] share price is $11.71. The Score for INKT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EXPGF Stock Price Chart

What is Experian Plc's stock price today?

  • The Experian Plc share price today is $45.61
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EXPGF is experiencing slight buying pressure.

INKT Stock Price Chart

What is MiNK Therapeutics, Inc.'s stock price today?

  • The MiNK Therapeutics, Inc. share price today is $11.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing selling pressure, which indicates risk of future bearish movement.

EXPGF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 60.89 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.44 - 45.02) Buy
Bollinger Bands (100): (45.3 - 52.06) Sell

INKT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 45.61 Sell
Chaikin Money Flow: -20975 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.89 - 12.65) Sell
Bollinger Bands (100): (12.3 - 15.28) Sell

EXPGF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.93 Buy
20-day SMA: 44.31 Buy
50-day SMA: 45.68 Sell
200-day SMA: 48.95 Sell
8-day EMA: 45.02 Buy
20-day EMA: 44.82 Buy
50-day EMA: 45.37 Buy
200-day EMA: 32.62 Buy

INKT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.32 Sell
20-day SMA: 11.56 Buy
50-day SMA: 12.92 Sell
200-day SMA: 11.86 Sell
8-day EMA: 12.05 Sell
20-day EMA: 12.05 Sell
50-day EMA: 12.68 Sell
200-day EMA: 12.23 Sell

Experian Plc Earnings Growth & EXPGF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.

Experian Plc Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

MiNK Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):